Clinical Trial

Effectiveness of a Therapeutic Exercise Program With Specific Upper Limb Exercises to Reduce Lymphedema and Neuropathy in Breast Cancer Patients: A Pre-post Study (LYNMA)

Study acronym: LYNMA
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 18, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the effectiveness of a therapeutic exercise program designed specifically for women with breast cancer. The program includes general exercises along with specific movements for the upper limb to help reduce common side effects of cancer treatment such as lymphedema (swelling of the arm) and neuropathy (nerve pain or numbness). Participants will undergo the exercise program and be assessed before and after to determine improvements in their symptoms and overall quality of life. The goal is to provide evidence that targeted physical therapy can improve recovery and well-being in breast cancer survivors.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-05.
Trial Details
NCT Number NCT07170631
Lead Sponsor Universitat Internacional de Catalunya
Collaborators: Consorci Sanitari de Terrassa
Conditions Lymphedema Arm, Lymphedema Due to Radiation, Lymphedema, Breast Cancer, Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathy in Breast Cancer Patient
Enrollment 30 participants
Start Date 2026-01
Primary Completion 2026-07 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-09-18